As a hallmark of apoptosis, we searched for cleaved PARP-1 after MEK6 silencing in two osteosarcoma cell lines (HOS and KHOS/NP) treated with pazopanib + trametinib combination. This evidence concerns the gene MAP2K6 and osteosarcoma.